Beta
Back to VEEV.US Analysis

Ticker

Value

empty

There is no following symbol in this watchlist.

  • Revenue by Segments
  • EPS
  • EPS Diluted
  • Revenue
  • Operation Income
  • Net Income
  • Operating Expenses
  • Cash Flow
  • Cash & Debt
  • Current Contract Liabilities
eps-diluted-chart

VEEV EPS Diluted

This disclaimer is provided by TradingValley Inc. and includes any messages, news, research, analysis, prices or other information provided by the Company's website, the application "Growin App" and other services provided through the Company's website. It is only general market information for educational and investment decision-making reference, and does not constitute any investment advice. View Growin Disclaimer

The latest data point for VEEV's diluted EPS in Q4'26 stands at 1.45 USD, reflecting a solid quarter-over-quarter increase from 1.40 USD in Q3'26 and marking the highest value in the observed period. Over the timeframe from Q1'24 to Q4'26, VEEV's diluted EPS has exhibited a consistent upward trend, rising from 0.81 USD to 1.45 USD, with an average quarterly growth of approximately 0.05 USD despite minor fluctuations, such as a dip to 0.68 USD in Q2'24. Year-over-year EPS growth has been predominantly positive, averaging around 25%, though it experienced a notable decline of -22.4% in Q4'24 before rebounding strongly with peaks like 52.9% in Q2'25, underscoring resilient profitability amid potential operational expansions in the healthcare IT sector.